600222 Stock Overview
Engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for 600222 from our risk checks.
Henan Taloph Pharmaceutical Stock Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.88 |
| 52 Week High | CN¥8.08 |
| 52 Week Low | CN¥3.75 |
| Beta | 0.59 |
| 11 Month Change | 11.42% |
| 3 Month Change | 16.19% |
| 1 Year Change | -12.70% |
| 33 Year Change | -41.56% |
| 5 Year Change | 6.78% |
| Change since IPO | -41.72% |
Recent News & Updates
Shareholder Returns
| 600222 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 13.0% | 6.5% | 9.6% |
| 1Y | -12.7% | -14.9% | -12.3% |
Return vs Industry: 600222 exceeded the CN Pharmaceuticals industry which returned -14.9% over the past year.
Return vs Market: 600222 matched the CN Market which returned -12.3% over the past year.
Price Volatility
| 600222 volatility | |
|---|---|
| 600222 Average Weekly Movement | 5.0% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.4% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 600222 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600222's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 2,353 | Jingliang Li | www.taloph.com |
Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, Danshen oral liquid, pediatric heat-clearing and cough-relieving oral liquid, pediatric compound chicken gizzard chewable tablets, and Huperzine A tablets. The company serves hospitals, primary medical institutions, and retail terminals.
Henan Taloph Pharmaceutical Stock Co.,Ltd Fundamentals Summary
| 600222 fundamental statistics | |
|---|---|
| Market cap | CN¥2.71b |
| Earnings (TTM) | CN¥108.51m |
| Revenue (TTM) | CN¥2.00b |
24.9x
P/E Ratio1.4x
P/S RatioIs 600222 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600222 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.00b |
| Cost of Revenue | CN¥1.42b |
| Gross Profit | CN¥582.31m |
| Other Expenses | CN¥473.80m |
| Earnings | CN¥108.51m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.20 |
| Gross Margin | 29.07% |
| Net Profit Margin | 5.42% |
| Debt/Equity Ratio | 51.1% |
How did 600222 perform over the long term?
See historical performance and comparison